AIM
PRCT icon

Aigen Investment Management’s Procept Biorobotics PRCT Stock Holding History

Aigen Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,976
Closed -$229K – 1032
2025
Q2 		$229K Sell
3,976
-267
-6% -$15.1K 0.03% 621
2025
Q1 		$247K Sell
4,243
-976
-19% -$66.6K 0.04% 566
2024
Q4 		$420K Buy
+5,219
New +$446K 0.07% 381
2024
Q2 		– Sell
-5,727
Closed -$283K – 970
2024
Q1 		$283K Buy
+5,727
New +$273K 0.06% 458

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Aigen Investment Management's PRCT Position: Q3 2025 in Review

Aigen Investment Management sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 3,976 shares — an estimated $229K sold.

Aigen Investment Management first reported a position in PRCT in Q1 2024 and held it in 4 quarters. The position peaked at $420K in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Aigen Investment Management reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Aigen Investment Management sold 3,976 Procept Biorobotics shares in Q3 2025, an estimated $229K.
  • Aigen Investment Management first reported a position in Procept Biorobotics in Q1 2024 and held it in 4 quarters.
  • Aigen Investment Management's Procept Biorobotics position peaked at $420K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.